tirzepatide heart Mounjaro, Zepbound Lowers Risk of Cardiovascular Death by 62% ESC 2025: study supports use

And so people that dont respond to SSRIs have high amounts of inflammation, which kind of raises this question of, is there a subset of depression thats really inflammatory driven, right

Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, distinguishing it from currently licensed therapies such as semaglutide and tirzepatide

The science of safety: Adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

Peptides work by acting as messengers in the body, signaling cells to perform specific functions, from releasing growth hormone to repairing tissue and regulating metabolism